Home / Inspections / 1270920

FDA Inspection 1270920 — Michigan Reproductive Medicine

Michigan Reproductive Medicine — FEI 3006074124

The FDA completed an inspection of Michigan Reproductive Medicine on May 13, 2025 in Bloomfield Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 13, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bloomfield Hills, MI (United States)

Facility

Other inspections at this facility

  • 1101342 (NAI Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023629 (NAI Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 959775 (NAI Wed Dec 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829763 (NAI Mon Apr 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 657404 (NAI Thu Apr 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources